Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SIEMENS HEALTHCARE A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   4.0% 1.1% 1.5% 1.3% 1.4% 1.6% 4.9% 4.9%   Credit score (0-100)   51 86 77 78 77 73 44 44   Credit rating   BBB A A A A A BBB BBB   Credit limit (mDKK)   -0.0 3.3 0.4 1.1 0.7 0.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   460 643 552 639 666 884 884 884   Gross profit   -367 84.6 98.8 107 146 163 0.0 0.0   EBITDA   22.7 15.8 26.3 29.4 50.1 52.6 0.0 0.0   EBIT   22.7 15.8 26.3 29.4 50.1 52.6 0.0 0.0   Pre-tax profit (PTP)   22.1 15.4 25.2 28.4 49.6 50.9 0.0 0.0   Net earnings   16.5 11.7 19.3 21.1 37.3 39.6 0.0 0.0   Pre-tax profit without non-rec. items   22.1 15.4 25.2 28.4 49.6 50.9 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   5.1 9.6 9.2 9.5 8.4 11.3 0.0 0.0   Shareholders equity total   54.2 50.2 57.9 60.0 76.3 121 80.6 80.6   Interest-bearing liabilities   0.3 0.5 0.6 16.2 2.9 156 0.0 0.0   Balance sheet total (assets)   232 214 252 277 393 548 80.6 80.6   Net Debt   0.3 0.5 0.6 16.2 2.9 96.6 -80.6 -80.6     See the entire balance sheet 1.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   460 643 552 639 666 884 884 884   Net sales growth   -21.6% 39.8% -14.1% 15.7% 4.2% 32.8% 0.0% 0.0%   Gross profit   -367 84.6 98.8 107 146 163 0.0 0.0   Gross profit growth   0.0% 0.0% 16.8% 8.4% 36.1% 11.6% -100.0% 0.0%   Employees   0 0 0 162 170 224 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 4.9% 31.8% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   232 214 252 277 393 548 81 81   Balance sheet change%   -14.5% -7.6% 17.6% 9.9% 41.9% 39.5% -85.3% 0.0%   Added value   22.7 15.8 26.3 29.4 50.1 52.6 0.0 0.0   Added value %   4.9% 2.5% 4.8% 4.6% 7.5% 5.9% 0.0% 0.0%   Investments   -16 -13 -0 0 -1 3 -11 0   Net sales trend   -1.0 1.0 -1.0 1.0 2.0 3.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   4.9% 2.5% 4.8% 4.6% 7.5% 5.9% 0.0% 0.0%   EBIT %   4.9% 2.5% 4.8% 4.6% 7.5% 5.9% 0.0% 0.0%   EBIT to gross profit (%)   -6.2% 18.7% 26.6% 27.4% 34.3% 32.3% 0.0% 0.0%   Net Earnings %   3.6% 1.8% 3.5% 3.3% 5.6% 4.5% 0.0% 0.0%   Profit before depreciation and extraordinary items %   3.6% 1.8% 3.5% 3.3% 5.6% 4.5% 0.0% 0.0%   Pre tax profit less extraordinaries %   4.8% 2.4% 4.6% 4.4% 7.5% 5.8% 0.0% 0.0%   ROA %   9.0% 7.1% 11.3% 11.1% 15.0% 11.5% 0.0% 0.0%   ROI %   22.7% 19.7% 36.0% 37.0% 58.0% 29.8% 0.0% 0.0%   ROE %   25.3% 22.4% 35.7% 35.8% 54.8% 40.2% 0.0% 0.0%   1.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   23.4% 23.4% 23.0% 21.7% 19.4% 22.0% 100.0% 100.0%   Relative indebtedness %   31.8% 21.8% 32.8% 32.2% 46.5% 46.8% 0.0% 0.0%   Relative net indebtedness %   31.8% 21.8% 32.8% 32.2% 46.5% 40.1% -9.1% -9.1%   Net int. bear. debt to EBITDA, %   1.3% 3.0% 2.2% 55.1% 5.9% 183.6% 0.0% 0.0%   Gearing %   0.6% 0.9% 1.0% 27.0% 3.8% 129.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8.8% 118.9% 212.7% 11.7% 7.5% 4.3% 0.0% 0.0%   1.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   1.4 1.4 1.3 1.2 1.2 1.2 0.0 0.0   Current Ratio   1.4 1.5 1.5 1.3 1.2 1.3 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 0.0 59.0 0.0 0.0   1.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   53.9 35.5 30.4 23.2 54.7 98.4 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   45.6% 31.8% 43.9% 41.8% 57.7% 60.7% 9.1% 9.1%   Net working capital   63.3 64.5 75.5 61.2 74.4 123.6 0.0 0.0   Net working capital %   13.8% 10.0% 13.7% 9.6% 11.2% 14.0% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 4 4 4 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0